Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

1.0K
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
1.0K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

279
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
279
Therapeutic Index01:13

Therapeutic Index

7.5K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.5K
Standards of Care II01:19

Standards of Care II

1.2K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.2K
Nursing Clinical Information System01:27

Nursing Clinical Information System

1.4K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.4K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

282
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
282

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson in the bb[over ¯] Final State Using pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Magnetic Monopole Pair Production in Ultraperipheral Pb+Pb Collisions at sqrt[s_{NN}]=5.36  TeV with the ATLAS Detector at the LHC.

Physical review letters·2025

Related Experiment Video

Updated: Mar 27, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K

CPDI: An Index for measuring deviations in Clinical Pathways.

M Zema, S Rosati, J E Duran Carvajal

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |January 7, 2016
    PubMed
    Summary

    This paper introduces a new system for measuring deviations from Clinical Pathways (CPs), which are structured guidelines for patient care. The system uses a Clinical Pathway Deviation Index (CPDI) to compare patient trajectories with established guidelines. The CPDI is based on five indicators and a weighted-sum model. Three tools for modeling CPs were tested, and two proved suitable for the system. A preliminary analysis was conducted using data from 24 real patient trajectories. The results suggest that the system can detect significant deviations in care delivery. The authors propose that CPDI can be used to monitor adherence to CPs and support quality improvement efforts.

    Keywords:
    clinical pathway adherencehealthcare quality metricsclinical decision supportmedical informatics tools

    Frequently Asked Questions

    More Related Videos

    Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion
    08:13

    Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion

    Published on: January 20, 2019

    7.2K
    Mapping Dysfunctional Protein-Protein Interactions in Disease
    09:39

    Mapping Dysfunctional Protein-Protein Interactions in Disease

    Published on: October 24, 2025

    1.0K

    Related Experiment Videos

    Last Updated: Mar 27, 2026

    Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
    03:08

    Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

    Published on: October 3, 2025

    1.1K
    Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion
    08:13

    Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion

    Published on: January 20, 2019

    7.2K
    Mapping Dysfunctional Protein-Protein Interactions in Disease
    09:39

    Mapping Dysfunctional Protein-Protein Interactions in Disease

    Published on: October 24, 2025

    1.0K

    Area of Science:

    • Healthcare quality improvement
    • Clinical decision support systems
    • Medical informatics

    Background:

    Clinical Pathways (CPs) serve as structured guidelines for managing patient care. Prior research has shown that CPs help reduce variability in clinical practice. However, deviations from these pathways may lead to reduced care quality. No prior work had resolved how to systematically measure these deviations. Existing studies focus on adherence metrics but lack a comprehensive index. This gap motivated the development of a new tool. The need for a quantitative measure of pathway adherence remains unmet. Researchers have proposed various models for CPs, but none integrate multiple indicators. This paper introduces a novel approach to assess deviations from CPs.

    Purpose Of The Study:

    The goal of this work is to introduce a system for measuring deviations from Clinical Pathways. The system compares patient trajectories with established guidelines. The authors aim to identify significant variations in care delivery. The focus is on developing a reliable index for pathway adherence. This approach seeks to improve the ability to monitor clinical performance. The study tests the feasibility of using multiple modeling tools. The system is designed to support quality improvement initiatives. The ultimate aim is to provide a quantitative tool for evaluating care deviations.

    Main Methods:

    The system compares patient trajectories with Clinical Pathways using a weighted-sum model. Five indicators were selected to measure adherence to CPs. Three tools for CP modeling were tested in the system's development. Only two of these tools proved suitable for the system's requirements. The Clinical Pathway Deviation Index (CPDI) was constructed using these indicators. A preliminary analysis was conducted on data from 24 real patient trajectories. The system's performance was evaluated based on these data. The methods focus on integrating multiple indicators into a single index.

    Main Results:

    The Clinical Pathway Deviation Index (CPDI) was successfully constructed using five indicators. The system was tested on data from 24 real patient trajectories. Two of the three modeling tools proved effective for the system. The preliminary analysis showed the system's ability to detect significant deviations. The weighted-sum model provided a reliable measure of pathway adherence. The results suggest that the system can identify variations in care delivery. The performance of the system was consistent across the tested data. The findings support the feasibility of using CPDI in clinical settings.

    Conclusions:

    The system successfully compared patient trajectories with Clinical Pathways. The Clinical Pathway Deviation Index (CPDI) was shown to be a viable tool. The preliminary analysis supported the system's ability to detect deviations. The system's performance was consistent across the tested data. Two of the three modeling tools proved suitable for the system. The findings suggest that the system can support quality improvement efforts. The authors propose that CPDI can be used to monitor adherence to CPs. The study demonstrates the feasibility of using a weighted-sum model for this purpose.

    The CPDI is a weighted-sum index that measures deviations from Clinical Pathways using five indicators.

    The preliminary analysis used data from 24 real patient trajectories.

    Only two of the three tools proved suitable for the system's requirements during testing.

    The weighted-sum model integrates five indicators into a single index to measure pathway adherence.

    The preliminary analysis showed the system's ability to detect significant deviations in care delivery.

    The authors propose that CPDI can be used to monitor adherence to Clinical Pathways in clinical settings.